BPC-157 10mg

Out of stock
Lot: OR-LPBPC10-326-B5
Grade: Laboratory
Purity: >99%
Vial Size: 3ml
Tested: Endotoxins, Heavy Metals, Microbials
U.S. Formulated: cGMP / ISO Aligned
UPS Shipping: Insurance Included
Arrives Lyophilized: Requires Reconstitution
Regular price $79.99 USD
Out of stock
Join the Restock List

Research Use Only

This product is limited to in vitro testing and laboratory experimentation only and is not for human or animal use or consumption of any kind. Handling and use are restricted to qualified or licensed professionals only, at least 21 years of age. Reconstitution Solution not included and sold separately. We are unable to provide guidance regarding research use or reconstitution.

Compound: BPC-157 10mg

Sequence:  Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Molecular Formula: C62H98N16O22

Molecular Weight: 1419.556 g/mol

PubChem CID: 9941957

CAS Number: 137525-51-0

Vial Size: 3ml 

  • Store at -20°C (freezer) for long-term stability.
  • Keep away from light, moisture, and heat.
  • Once reconstitued store at 2-8°C (refrigerator).
  • Discard any solution that becomes discolored or shows signs of contamination.

This product is supplied as a lyophilized powder and is intended strictly for research use only. Researchers are solely responsible for the appropriate reconstitution of all OROS research compounds. Reconstitution Solution is sold separately. We do not sell syringes, nor do we provide instructions on mixing, dosing, or any research protocols.

This product is limited to in vitro testing and laboratory experimentation and is not intended for human or animal use or consumption under any circumstances. Handling and use are restricted to qualified or licensed professionals only.

This product is not FDA approved and is not classified as a drug, food, or cosmetic. It may not be represented, marketed, or used as such

All orders placed through OROS Research are shipped via UPS (free 2-day shipping on orders over $150), and includes full insurance in the event your package is lost, stolen, or damaged in transit.

Once your order is handed off to UPS, delivery times are no longer within our control. While most shipments arrive within 2–5 business days, delays may occur due to weather conditions, holidays, high-volume periods, or weekend inactivity, during which packages are not in transit.

To help ensure product integrity during transit, all research materials are packaged in protective boxes that shield vials from direct sunlight and temperature fluctuations. Additionally, our lyophilized (freeze-dried) research peptides are highly stable and can withstand elevated temperatures for extended periods of time without compromising quality or efficacy. Because of this, we do not ship with cold packs.

Rated Excellent on Trustpilot
Read our reviews

Comprehensive Multi-Point Quality Verification

Every OROS batch is verified across seven critical quality attributes—including identity, purity, net content, multi-vial variance, endotoxins, heavy metals, and microbial—ensuring a high level of analytical integrity, consistency, and transparency. This multi-point framework represents one of the most comprehensive testing standards in the research space.

April 2026 Update: All new batches are now validated through an ISO 17025-accredited laboratory, supporting method accuracy, reproducibility, and compliance with recognized analytical standards. Residual solvent analysis will be incorporated next as part of the continued expansion of our quality control program.

Identity

Verified

Confirms the molecular identity of the compound against validated reference standards. Identity verification is foundational to ensure the material being analyzed is correct and properly characterized.

Net Content

Verified

Verifies that each vial meets its labeled quantity within acceptable variance. Accurate net content supports consistency across batches and reliability in downstream applications.

Purity (HPLC)

Passed

Assessed via High-Performance Liquid Chromatography (HPLC) to quantify the target compound and detect impurities. High purity reduces the presence of unintended constituents that may affect analytical outcomes.

Conformity (Vial-to-Vial)

Passed

Evaluates multiple units within a single lot to confirm uniformity across vials. This helps ensure consistent composition and performance at the batch level.

Endotoxins (USP <85>)

Passed

Measures bacterial endotoxin levels using validated methods. Endotoxin control is critical for minimizing biological interference and maintaining integrity in sensitive analytical systems.

Heavy Metals (USP <233>)

Passed

Screens for elemental impurities such as lead, arsenic, cadmium, and mercury. Monitoring trace metals supports material purity and overall quality assurance.

Microbial (USP <61>, USP <62>)

Passed

Assesses total microbial burden and specified organisms to confirm compliance with microbiological quality standards. This helps ensure controlled, clean finished material.

Residual Solvents

Coming Soon

Will evaluate trace residual solvents from synthesis or processing. This additional analysis will further strengthen the overall completeness of batch-level quality assessment.

5-Amino-1MQ 50mg
0 Records
Compound: 5-Amino-1MQ 50mg
Current Lot
Net Weight
50.88mg
Purity
99%
Lot Number
OR-LP5A150-526-B1
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
AOD-9064
0 Records
Compound: AOD-9604 5mg
Net Weight
7.48mg
Purity
99%
Lot Number
1135493 - Batch 1
MFG Date
December 2025
EXP Date
December 2027
COA Date
January 9th 2026
Purchase Start
January 11th 2026
Purchase End
March 24th 2026
Compound: AOD-9604 5mg
Current Lot
Net Weight
5.21mg
Purity
99%
Lot Number
OR-LPAOD5-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 9th 2026
Purchase End
Present
AURA
0 Records
Net Weight
100mg
Purity
99%
Lot Number
938536 - Batch 1
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 18th 2025
Purchase Start
November 18th 2025
Purchase End
Present
BPC-157
0 Records
Compound: BPC-157 5mg
Net Weight
5.07mg
Purity
99%
Lot Number
395247 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
September 23rd 2025
Compound: BPC-157 5mg
Net Weight
6.13mg
Purity
99%
Lot Number
413358 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
September 23rd 2025
Purchase Start
September 23rd 2025
Purchase End
November 7th 2025
Compound: BPC-157 5mg
Net Weight
6.84mg
Purity
99%
Lot Number
835571 - Batch 3
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 28th 2025
Purchase Start
November 28th 2025
Purchase End
January 19th 2026
Compound: BPC-157 10mg
Net Weight
14.52mg
Purity
99%
Lot Number
863923 - Batch 1
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 13th 2025
Purchase Start
December 13th 2025
Purchase End
January 28th 2026
Compound: BPC-157 5mg
Net Weight
5.59mg
Purity
99%
Lot Number
1323471 - Batch 4
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 3rd 2026
Purchase Start
February 4th 2026
Purchase End
May 16th 2026
Compound: BPC-157 10mg
Net Weight
11.16mg
Purity
99%
Lot Number
1349811 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 3rd 2026
Purchase Start
February 4th 2026
Purchase End
March 25th 2026
Compound: BPC-157 10mg
Current Lot
Net Weight
10.16mg
Purity
99%
Lot Number
OR-LPBPC10-326-B5
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
Present
Compound: BPC-157 5mg
Current Lot
Net Weight
5.02mg
Purity
99%
Lot Number
OR-LPBPC5-526-B5
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
BPC-157 Capsules
0 Records
Net Weight
500mcg
Purity
Lot Number
73956 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 27th 2025
Purchase Start
November 6th 2025
Purchase End
April 16th 2026
Net Weight
536.59
Purity
Lot Number
OR-CBPC500-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Cartalax
0 Records
Compound: Cartalax 20mg
Current Lot
Net Weight
19.30mg
Purity
99%
Lot Number
OR-CTX20-326 - Batch 1
MFG Date
March 2026
EXP Date
March 2028
COA Date
March 27th 2026
Purchase Start
March 27th 2026
Purchase End
Present
CJC-1295 (DAC)
0 Records
Compound: CJC-1295 DAC 5mg
Net Weight
6.04mg
Purity
99%
Lot Number
538577 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 12th 2025
Purchase Start
October 12th 2025
Purchase End
November 30th 2025
Compound: CJC-1295 DAC 5mg
Net Weight
7.43mg
Purity
99%
Lot Number
829471 - Batch 2
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
January 3rd 2026
Compound: CJC-1295 DAC 5mg
Net Weight
6.95mg
Purity
99%
Lot Number
1246331 - Batch 3
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 2nd 2026
Purchase End
April 8th 2026
Compound: CJC-1295 DAC 5mg
Current Lot
Net Weight
5.16mg
Purity
99%
Lot Number
OR-LPCJC5-426-B5
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
CJC-1295 / Ipamorelin
0 Records
Net Weight
10.30mg
Purity
99%
Lot Number
395292 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
August 12th 2025
Purchase Start
August 12th 2025
Purchase End
September 1st 2025
Net Weight
12.06mg
Purity
99%
Lot Number
416313 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 2nd 2025
Purchase Start
October 2nd 2025
Purchase End
October 10th 2025
Net Weight
11.8mg
Purity
99%
Lot Number
727449 - Batch 3
MFG Date
October 2025
EXP Date
October 2027
COA Date
November 7th 2026
Purchase Start
November 10th 2025
Purchase End
November 30th 2025
Net Weight
11.35mg
Purity
99%
Lot Number
853822 - Batch 4
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
December 26th 2025
Net Weight
9.85mg
Purity
99%
Lot Number
1136576 - Batch 5
MFG Date
December 2025
EXP Date
December 2027
COA Date
January 9th 2026
Purchase Start
January 11th 2026
Purchase End
January 31st 2026
Net Weight
10.76mg
Purity
99%
Lot Number
1247385 - Batch 6
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 2nd 2026
Purchase End
February 13th 2026
Net Weight
10.42mg
Purity
99%
Lot Number
1536499 - Batch 7
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 17th 2026
Purchase Start
February 19th 2026
Purchase End
March 28th
Net Weight
22.34mg
Purity
99%
Lot Number
1624882 - Batch 1
MFG Date
February 2026
EXP Date
February 2026
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
March 30th 2026
Net Weight
10.19mg
Purity
99%
Lot Number
OR-LPCJCIPA10-326-B8
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
May 14th 2026
Net Weight
20.47mg
Purity
99%
Lot Number
OR-LPCJCIPA20-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
Present
Net Weight
10.20mg
Purity
99%
Lot Number
OR-LPCJCIPA10-526-B9
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
CJC-1295 (No DAC)
0 Records
Net Weight
5.21mg
Purity
99%
Lot Number
395253 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
October 1st 2025
Net Weight
5.79mg
Purity
99%
Lot Number
416355 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 2nd 2025
Purchase Start
October 2nd 2025
Purchase End
December 9th 2025
Net Weight
6.12mg
Purity
99%
Lot Number
831643 - Batch 3
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
February 17th 2026
Net Weight
5.63mg
Purity
99%
Lot Number
1525387 - Batch 4
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 17th 2026
Purchase Start
February 19th 2026
Purchase End
May 18th 2026
Current Lot
Net Weight
5.19mg
Purity
99%
Lot Number
OR-LP-CJCND5-526-B5
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
DSIP
0 Records
Compound: DSIP 5mg
Net Weight
5.19mg
Purity
99%
Lot Number
1627401 - Batch 1
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
May 12th 2026
Compound: DSIP 5mg
Current Lot
Net Weight
5.13mg
Purity
99%
Lot Number
OR-LPDSP5-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Epithalon
0 Records
Net Weight
8.17mg
Purity
99%
Lot Number
549788 - Batch 1
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 12th 2025
Purchase Start
October 13th 2025
Purchase End
December 21st 2025
Net Weight
18.41mg
Purity
99%
Lot Number
1485469 - Batch 1
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 11th 2026
Purchase Start
February 12th 2026
Purchase End
March 25th 2026
Net Weight
10.14mg
Purity
99%
Lot Number
OR-LPEPI10-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 9th 2026
Purchase End
May 14th 2026
Current Lot
Net Weight
10.04mg
Purity
99%
Lot Number
OR-LPEPI10-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
GHK-Cu
0 Records
Compound: GHK‐Cu 50mg
Net Weight
49.50mg
Purity
99%
Lot Number
395291 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 12th 2025
Purchase Start
July 15th 2025
Purchase End
October 19th 2025
Compound: GHK‐Cu 50mg
Net Weight
48.18mg
Purity
99%
Lot Number
416312 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
September 23rd 2025
Purchase Start
October 20th 2025
Purchase End
December 26th 2025
Compound: GHK‐Cu 50mg
Net Weight
51.70mg
Purity
99%
Lot Number
863901 - Batch 3
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 26th 2025
Purchase End
February 4th 2026
Compound: GHK‐Cu 50mg
Net Weight
51.04mg
Purity
99%
Lot Number
1462133 - Batch 4
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 9th 2026
Purchase End
February 28th 2026
Compound: GHK‐Cu 50mg
Net Weight
55.07mg
Purity
99%
Lot Number
1623175 - Batch 5
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
April 17th 2026
Compound: GHK‐Cu 50mg
Current Lot
Net Weight
51.79mg
Purity
99%
Lot Number
OR-LPGHK50-426-B6
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
GLOW
0 Records
Net Weight
96.13mg
Purity
99%
Lot Number
416314 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 4th 2025
Purchase Start
October 5th 2025
Purchase End
November 27th 2025
Net Weight
91.07mg
Purity
99%
Lot Number
395293 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 12th 2025
Purchase Start
July 21st 2025
Purchase End
August 25 2025
Net Weight
68.8mg
Purity
99%
Lot Number
1321546 - Batch 1
MFG Date
January 2026
EXP Date
January 2028
COA Date
January 12th 2026
Purchase Start
January 13th 2026
Purchase End
March 20th 2026
Net Weight
81.19mg
Purity
99%
Lot Number
OR-GLW-326-B4
MFG Date
March 2026
EXP Date
March 2028
COA Date
March 21st 2026
Purchase Start
March 22nd 2026
Purchase End
April 27th 2026
Net Weight
72.23mg
Purity
99%
Lot Number
OR-LPGL70-426-B5
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
GLP-1R (Reta)
0 Records
Compound: GLP-1R (GLP3) 5mg
Net Weight
5.96mg
Purity
99%
Lot Number
427458 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 2nd 2025
Purchase Start
October 4th 2025
Purchase End
February 8th 2026
Compound: GLP-1R (GLP3) 10mg
Net Weight
11.07mg
Purity
99%
Lot Number
395237 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 7th 2025
Purchase Start
July 15th 2025
Purchase End
October 8th 2025
Compound: GLP-1R (GLP3) 10mg
Net Weight
13.17mg
Purity
99%
Lot Number
416347 - Batch 2
MFG Date
September 2025
EXP Date
September 2026
COA Date
September 23rd 2025
Purchase Start
October 10th 2025
Purchase End
December 8th 2025
Compound: GLP-1R (GLP3) 10mg
Net Weight
12.53mg
Purity
99%
Lot Number
817359 - Batch 3
MFG Date
November 2025
EXP Date
November 2026
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
January 27th 2026
Compound: GLP-1R (GLP3) 20mg
Net Weight
20.07mg
Purity
99%
Lot Number
933107 - Batch 1
MFG Date
December 2025
EXP Date
December 2026
COA Date
December 19th 2025
Purchase Start
December 19th 2025
Purchase End
April 23rd 2026
Compound: GLP-1R (GLP3) 10mg
Net Weight
10mg
Purity
99%
Lot Number
1316243 - Batch 4
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 3rd 2026
Purchase Start
February 4th 2026
Purchase End
March 9th 2026
Compound: GLP-1R (GLP3) 5mg
Net Weight
5.54mg
Purity
99%
Lot Number
1473244 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 9th 2026
Purchase End
May 5th 2026
Compound: GLP-1R (GLP3) 10mg
Net Weight
10.88mg
Purity
99%
Lot Number
1724211 - Batch 5
MFG Date
February 2026
EXP Date
February 2028
COA Date
March 10th 2026
Purchase Start
March 11th 2026
Purchase End
May 5th 2026
Compound: GLP-1R (GLP3) 20mg
Net Weight
20.86mg
Purity
99%
Lot Number
OR-LPGLPR10-326-B2
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 9th 2026
Purchase Start
April 23rd 2026
Purchase End
June 1st 2026
Compound: GLP-1R (GLP3) 10mg
Current Lot
Net Weight
10.26mg
Purity
99%
Lot Number
OR-LPGLPR10-426-B6
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
Compound: GLP-1R (GLP3) 5mg
Current Lot
Net Weight
5.19mg
Purity
99%
Lot Number
OR-LPGLPR5-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
GLP-1S (Sema)
0 Records
Compound: GLP-1S (GLP1) 5mg
Current Lot
Net Weight
5.45mg
Purity
99%
Lot Number
395255 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
Present
Compound: GLP-1S (GLP1) 10mg
Net Weight
10.66mg
Purity
99%
Lot Number
395224 - Batch 1
MFG Date
July 2025
EXP Date
July 2026
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
November 1st 2025
Compound: GLP-1S (GLP1) 10mg
Net Weight
13.99mg
Purity
99%
Lot Number
877136 - Batch 2
MFG Date
November 2025
EXP Date
November 2026
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
April 9th 2026
Compound: GLP-1S (GLP1) 10mg
Current Lot
Net Weight
10.33mg
Purity
99%
Lot Number
OR-LPGLPS10-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
GLP-1T (Tirz)
0 Records
Compound: GLP-1T (GLP2) 5mg
Net Weight
5.30mg
Purity
99%
Lot Number
395255 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
May 5th 2026
Compound: GLP-1T (GLP2) 10mg
Net Weight
10.18mg
Purity
99%
Lot Number
876254 - Batch 2
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 12th 2025
Purchase Start
January 13th 2025
Purchase End
April 7th 2026
Compound: GLP-1T (GLP2) 10mg
Net Weight
10.64mg
Purity
99%
Lot Number
395236 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
January 12th 2025
Compound: GLP-1T (GLP2) 10mg
Current Lot
Net Weight
10.23mg
Purity
99%
Lot Number
OR-LPGLPT10-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
Compound: GLP-1T (GLP2) 5mg
Current Lot
Net Weight
5.31mg
Purity
99%
Lot Number
OR-LPGLPT5-426-B2
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
May 5th 2026
Purchase End
Present
Gut Matrix
0 Records
Net Weight
207.13mg
Purity
Lot Number
OR-CGMTX201-526-B1
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Ipamorelin
0 Records
Compound: Ipamorelin 5mg
Net Weight
5.47mg
Purity
99%
Lot Number
395256 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
October 20th 2025
Compound: Ipamorelin 5mg
Net Weight
6.09mg
Purity
99%
Lot Number
416367 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
September 23rd 2025
Purchase Start
October 20th 2025
Purchase End
January 31st 2026
Compound: Ipamorelin 5mg
Net Weight
5.01mg
Purity
99%
Lot Number
1243137 - Batch 3
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 2nd 2026
Purchase End
April 8th 2026
Compound: Ipamorelin 5mg
Current Lot
Net Weight
5.24mg
Purity
99%
Lot Number
OR-LPIPA5-426-B4
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
Kisspeptin-10
0 Records
Compound: Kisspeptin-10 5mg
Current Lot
Net Weight
4.78mg
Purity
99%
Lot Number
359289 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 12th 2025
Purchase Start
July 15th 2025
Purchase End
Present
KLOW
0 Records
Net Weight
83.31mg
Purity
99%
Lot Number
943117 - Batch 1
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 17th 2025
Purchase Start
December 17th 2025
Purchase End
March 26th 2026
Net Weight
88.47mg
Purity
99%
Lot Number
OR-LPKLO80-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 1st 2026
Purchase Start
April 1st 2026
Purchase End
April 10th 2026
Net Weight
83.34mg
Purity
99%
Lot Number
OR-LPKLO80-326-B3
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
May 10th 2026
Net Weight
82.46mg
Purity
99%
Lot Number
OR-LPKLO80-526-B4
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
KPV
0 Records
Compound: KPV 15mg
Net Weight
15.96mg
Purity
99%
Lot Number
793221 - Batch 1
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 15th 2025
Purchase Start
November 15th 2025
Purchase End
April 28th 2026
Compound: KPV 15mg
Current Lot
Net Weight
15.39mg
Purity
99%
Lot Number
OR-LPKPV15-426-B2
MFG Date
April 2026
EXP Date
April 2026
COA Date
April 16th 2026
Purchase Start
April 29th 2026
Purchase End
Present
Melanotan-2
0 Records
Compound: Melanotan-2 10mg
Net Weight
10.74mg
Purity
99%
Lot Number
395221 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
September 15th 2025
Compound: Melanotan-2 10mg
Net Weight
9.77mg
Purity
99%
Lot Number
395362 - Batch 2
MFG Date
August 2025
EXP Date
August 2027
COA Date
August 23rd 2025
Purchase Start
September 16th 2025
Purchase End
November 27th 2025
Compound: Melanotan-2 10mg
Net Weight
12.18mg
Purity
99%
Lot Number
8714419 - Batch 3
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 12th 2025
Purchase Start
December 12th 2025
Purchase End
February 28th 2026
Compound: Melanotan-2 10mg
Net Weight
9.88mg
Purity
99%
Lot Number
1621439 - Batch 4
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2028
Purchase Start
February 28th 2028
Purchase End
March 30th 2026
Compound: Melanotan-2 10mg
Current Lot
Net Weight
10.18mg
Purity
99%
Lot Number
OR-LPMT2-426-B5
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
MOTS-C
0 Records
Compound: MOTS-C 10mg
Net Weight
9.77mg
Purity
99%
Lot Number
395233 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
September 30th 2025
Compound: MOTS-C 10mg
Net Weight
11.68mg
Purity
99%
Lot Number
855216 - Batch 3
MFG Date
November 2025
EXP Date
November 2026
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
January 10th 2026
Compound: MOTS-C 10mg
Net Weight
9.63mg
Purity
99%
Lot Number
416344 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 6th 2025
Purchase Start
October 6th 2025
Purchase End
November 21st 2025
Compound: MOTS-C 10mg
Net Weight
10.84mg
Purity
99%
Lot Number
1125231 - Batch 4
MFG Date
December 2025
EXP Date
December 2025
COA Date
January 9th 2026
Purchase Start
January 11th 2026
Purchase End
February 6th 2026
Compound: MOTS-C 10mg
Net Weight
10.13mg
Purity
99%
Lot Number
1244163 - Batch 5
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 7th 2026
Purchase End
February 26th 2026
Compound: MOTS-C 10mg
Net Weight
9.82mg
Purity
98%
Lot Number
1622733 - Batch 6
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
April 4th 2026
Compound: MOTS-C 10mg
Current Lot
Net Weight
10.29mg
Purity
99%
Lot Number
OR-LPMOTS10-426-B7
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
Compound: MOTS-C 20mg
Current Lot
Net Weight
20.78mg
Purity
99%
Lot Number
OR-LPMOTS20-426-B1
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 13th 2026
Purchase Start
May 14th 2026
Purchase End
Present
NAD+
0 Records
Compound: NAD+ 500mg
Net Weight
549.12mg
Purity
99%
Lot Number
398321 - Batch 1
MFG Date
August 2025
EXP Date
August 2027
COA Date
September 6th 2025
Purchase Start
September 15th 2025
Purchase End
November 19th 2025
Compound: NAD+ 500mg
Net Weight
544.17mg
Purity
99%
Lot Number
996575 - Batch 2
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 30th 2025
Purchase Start
December 30th 2025
Purchase End
February 2nd 2026
Compound: NAD+ 500mg
Net Weight
499.44mg
Purity
99%
Lot Number
1781124 - Batch 3
MFG Date
February 2026
EXP Date
February 2028
COA Date
March 10th 2026
Purchase Start
March 11th 2026
Purchase End
April 30th 2026
Pinealon
0 Records
Compound: Pinealon 20mg
Current Lot
Net Weight
21.57mg
Purity
99%
Lot Number
1746845 - Batch 1
MFG Date
February 2026
EXP Date
February 2028
COA Date
March 10th 2026
Purchase Start
March 11th 2026
Purchase End
Present
PT-141
0 Records
Compound: PT-141 10mg
Net Weight
11.59mg
Purity
99%
Lot Number
998557 - Batch 1
MFG Date
December 2025
EXP Date
December 2027
COA Date
January 5th 2026
Purchase Start
January 6th 2026
Purchase End
March 1st 2026
Compound: PT-141 10mg
Net Weight
10.30mg
Purity
99%
Lot Number
1434582 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
March 1st 2026
Purchase End
April 30th 2026
Compound: PT-141 10mg
Current Lot
Net Weight
10.08mg
Purity
99%
Lot Number
OR-LPPT10-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
Reconstitution Solution
0 Records
REGEN
0 Records
Net Weight
40.56mg
Purity
99%
Lot Number
1513276 - Batch 1
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 17th 2026
Purchase Start
February 19th 2026
Purchase End
Present
Selank N-Acetyl Amidate
0 Records
Net Weight
9.51mg
Purity
99%
Lot Number
1626694 - Batch 1
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
May 21st 2026
Current Lot
Net Weight
10.19mg
Purity
99%
Lot Number
OR-LPNASLK10-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Semax N-Acetyl Amidate
0 Records
Net Weight
29.12mg
Purity
99%
Lot Number
1625200 - Batch 1
MFG Date
February 2026
EXP Date
February 2026
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
April 29th 2026
Current Lot
Net Weight
31.27mg
Purity
99%
Lot Number
OR-LPNASMX30-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Semax / Selank N-Acetyl
0 Records
Net Weight
15.97mg
Purity
99%
Lot Number
983653 - Batch 1
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 26th 2025
Purchase Start
December 26th 2025
Purchase End
April 6th 2026
Net Weight
15.25mg
Purity
99%
Lot Number
OR-LPNASML15-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
March 31st
Purchase Start
April 6th 2026
Purchase End
Present
Sermorelin
0 Records
Compound: Sermorelin 5mg
Net Weight
4.23mg
Purity
99%
Lot Number
395297 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 12th 2025
Purchase Start
July 15th 2025
Purchase End
October 10th 2025
Compound: Sermorelin 5mg
Net Weight
5.04mg
Purity
99%
Lot Number
416318 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
September 23rd 2025
Purchase Start
October 10th 2025
Purchase End
February 1st 2026
Compound: Sermorelin 5mg
Net Weight
5.90mg
Purity
99%
Lot Number
1451922 - Batch 3
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 9th 2026
Purchase End
April 29th 2026
Compound: Sermorelin 5mg
Current Lot
Net Weight
5.20mg
Purity
99%
Lot Number
OR-LPSERM5-426-B4
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 29th 2026
Purchase End
Present
Sermorelin / Ipamorelin
0 Records
Net Weight
14.24mg
Purity
99%
Lot Number
795263 - Batch 1
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 15th 2025
Purchase Start
November 15th 2025
Purchase End
January 22nd 2026
Net Weight
9.67mg
Purity
99%
Lot Number
1245860 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 2nd 2026
Purchase End
April 21st 2026
Net Weight
10.21mg
Purity
99%
Lot Number
OR-LPSERMIPA10-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
SLU-PP-332 Capsules
0 Records
Current Lot
Net Weight
1053.16mcg/Capsule
Purity
Lot Number
OR-CSLU1000-426-B1
MFG Date
April 2026
EXP Date
April 2027
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
SS-31, MOTS-C Blend
0 Records
Net Weight
20.40mg
Purity
99%
Lot Number
OR-LPSSMC20-326-B1
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
April 26th 2026
Current Lot
Net Weight
20.11mg
Purity
99%
Lot Number
OR-LPSSMC20-526-B2
MFG Date
May 2026
EXP Date
May2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
TB-500
0 Records
Net Weight
5.54mg
Purity
99%
Lot Number
395234 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 23rd 2025
Purchase End
November 21st 2025
Current Lot
Net Weight
6.24mg
Purity
99%
Lot Number
825570 - Batch 2
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 28th 2025
Purchase Start
November 28th
Purchase End
Present
Net Weight
9.94mg
Purity
98%
Lot Number
427456 - Batch 1
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 4th 2025
Purchase Start
October 6th 2025
Purchase End
January 13th 2026
Net Weight
9.94mg
Purity
98%
Lot Number
1356233 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
January 12th 2026
Purchase Start
January 13th 2026
Purchase End
April 9th 2026
Current Lot
Net Weight
10.22mg
Purity
99%
Lot Number
OR-LPTB10-326-B5
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th
Purchase End
Present
Tesamorelin
0 Records
Compound: Tesamorelin 5mg
Net Weight
5.76mg
Purity
99%
Lot Number
395254 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 3rd 2025
Purchase Start
July 15th 2025
Purchase End
September 2nd 2025
Compound: Tesamorelin 5mg
Net Weight
6.63mg
Purity
99%
Lot Number
398321 - Batch 2
MFG Date
August 2025
EXP Date
August 2027
COA Date
September 15th 2025
Purchase Start
September 15th 2025
Purchase End
October 23rd 2025
Compound: Tesamorelin 5mg
Net Weight
5.34mg
Purity
99%
Lot Number
74659 - Batch 3
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 31st 2025
Purchase Start
October 31st 2025
Purchase End
January 29th 2026
Compound: Tesamorelin 5mg
Net Weight
5.20mg
Purity
99%
Lot Number
1449647 - Batch 4
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 9th 2026
Purchase End
March 13th 2026
Compound: Tesamorelin 5mg
Net Weight
5.11mg
Purity
99%
Lot Number
OR-LPTES5-326-B5
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
May 13th 2026
Compound: Tesamorelin 10mg
Current Lot
Net Weight
10.14mg
Purity
99%
Lot Number
OR-LPTES10-426-B1
MFG Date
May 2026
EXP Date
May 20228
COA Date
May 2nd 2026
Purchase Start
May 14th 2026
Purchase End
Present
Compound: Tesamorelin 5mg
Current Lot
Net Weight
5.06mg
Purity
99%
Lot Number
OR-LPTES5-526-B6
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Tesamorelin / Ipamorelin
0 Records
Net Weight
20.34mg
Purity
99%
Lot Number
776843 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
November 7th 2025
Purchase Start
November 7th 2025
Purchase End
February 20th 2026
Net Weight
21.02mg
Purity
99%
Lot Number
1427354 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 20th 2026
Purchase End
March 30th 2026
Net Weight
20.39mg
Purity
99%
Lot Number
OR-LPTESIPA20-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
Testagen
0 Records
Compound: Testagen 20mg
Current Lot
Net Weight
20.58mg
Purity
99%
Lot Number
OR-LPTST20-426-B1
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
Thymosin Alpha-1
0 Records
Current Lot
Net Weight
5.18mg
Purity
99%
Lot Number
OR-LPTA5-326-B1
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
Present
Wolverine - BPC-157 / TB-500
0 Records
Net Weight
11.25mg
Purity
99%
Lot Number
395253 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
September 29th 2025
Net Weight
11.17mg
Purity
98%
Lot Number
817358 - Batch 2
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 8th 2025
Purchase End
December 31st 2025
Net Weight
21.94mg
Purity
98%
Lot Number
1248671 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
January 13th 2026
Purchase Start
January 13th 2026
Purchase End
February 8th 2026
Net Weight
20.19mg
Purity
98%
Lot Number
527457 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 12th 2025
Purchase Start
October 13th 2025
Purchase End
November 18th 2025
Net Weight
12.15mg
Purity
99%
Lot Number
1338536 - Batch 3
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 3rd 2026
Purchase Start
February 4th 2026
Purchase End
April 6th 2026
Net Weight
21.98mg
Purity
99%
Lot Number
1547512 - Batch 3
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 17th 2026
Purchase Start
February 19th 2026
Purchase End
April 23rd 2026
Net Weight
10.49mg
Purity
99%
Lot Number
OR-LPBPCTB10-426-B4
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
Net Weight
20.32mg
Purity
99%
Lot Number
OR-LPBPCTB20-326-B4
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 9th 2026
Purchase Start
April 23rd 2026
Purchase End
Present
Semax N-Acetyl Amidate 30mg - OROS Research

Science Without Shortcuts™

Founded in 2025, OROS Research was created with a singular mission: to bring integrity, transparency, and uncompromising quality to the research peptide industry. Born out of frustration with a market saturated by corner-cutting and profit-first mindsets, we set out to redefine what researchers should expect and deserve.

At OROS, we manufacture our peptides in California in an ISO 5 Laminar Flow Facility following cGMP standards, ensuring every product meets the highest standards of purity, and precision. We don’t just claim quality, we prove it through rigorous testing and verifiable third-party COAs provided by licensed testing facilities in the U.S.

Built by researchers, for researchers, we believe in doing things the right way. No shortcuts, no gray areas, and no false promises. Just high-purity, genuine USA-made peptides, reliable service, and a relentless focus on helping our research customers achieve meaningful results.

Learn More

Frequently Asked Questions

Answers to our most common questions.

What is this product for?

This product is intended strictly for in-vitro laboratory research use only. It is not intended for human or animal consumption, medical use, cosmetic use, diagnostic use, therapeutic use, compounding, or resale as a finished drug product.

OROS Research products are not drugs, medications, dietary supplements, food products, cosmetics, or medical devices.

Are your products tested?

Yes. Every newly released OROS lyophilized batch undergoes independent third-party testing prior to release. As of April 2026, all new OROS lyophilized product batches are tested through independent ISO-accredited laboratories.

Depending on the product type, testing may include identity confirmation, chromatographic purity by HPLC, net content verification, endotoxins, heavy metals, microbial contamination, residual solvents, and multi-vial conformity testing.

We believe quality is best evaluated through multiple analytical tests rather than relying on purity alone. This broader approach helps support batch consistency, transparency, and overall product quality.

Who performs your testing?

As of April 2026, all new OROS lyophilized product batches are tested by independent ISO/IEC 17025-accredited laboratories in the United States.

ISO/IEC 17025 is an internationally recognized quality standard for testing laboratories and supports analytical accuracy, reproducibility, traceability, and validated testing methods.

Testing is performed independently from manufacturing operations to provide objective analytical results and an additional layer of transparency.

Why do your COAs show “>99%” purity instead of decimal values?

Our testing partner, Ethos Analytics, reports purity as “>99% Chromatographic Purity by HPLC” rather than emphasizing small decimal differences such as 99.23% versus 99.56%.

At these levels, minor decimal differences may reflect normal analytical variation, sample preparation, instrument response, integration settings, or testing conditions rather than a meaningful difference in product quality.

From a scientific standpoint, the more important questions are whether identity was confirmed, whether the batch meets chromatographic purity specifications, and whether the vial contains the labeled amount of peptide.

We believe this approach helps prevent researchers from overinterpreting insignificant purity differences that may not meaningfully impact product quality.

What does chromatographic purity actually mean?

The purity values reported on our COAs represent chromatographic purity by HPLC. This measures the percentage of the target peptide peak relative to other detectable peaks under specific analytical conditions.

Chromatographic purity does not mean that 99% of the total powder mass in the vial is peptide. Lyophilized products may contain stabilizers, bulking agents, salts, buffers, residual moisture, counterions, and other formulation-related components that support manufacturing, stability, and lyophilization performance.

This is why we identify the result as chromatographic purity by HPLC rather than simply listing “purity.” We believe researchers should understand exactly what is being measured and how that result should be interpreted.

Is purity the most important test?

Purity is an important quality indicator, but it is only one part of the overall quality picture.

A highly pure peptide still needs to have its identity confirmed, its labeled peptide content verified, and its batch screened for contaminants such as endotoxins, heavy metals, microbial contamination, and residual solvents.

OROS Research places significant emphasis on both purity testing and quantitative content verification because confirming that a vial contains the labeled amount of peptide is critical to overall batch quality and transparency.

Why does OROS Research perform testing beyond purity?

Purity testing is an important component of quality verification, but purity alone does not provide a complete picture of overall batch quality. A material may achieve a high purity result while still containing contaminants, inconsistencies, or other quality concerns that are not identified through purity testing alone.

For this reason, OROS Research utilizes a comprehensive testing program designed to evaluate multiple quality attributes beyond identity and purity. Depending on the product type, testing may include net content verification, multi-vial conformity testing, endotoxin screening, heavy metal analysis, microbial testing, and residual solvent analysis.

Endotoxin testing screens for bacterial byproducts that may interfere with certain laboratory applications and research outcomes. Heavy metal testing evaluates trace elemental contaminants that may be introduced through raw materials, manufacturing equipment, water sources, or the production environment.

Microbial testing screens for microorganisms that may be introduced during manufacturing, handling, packaging, or storage. Residual solvent analysis evaluates solvents that may remain from manufacturing, purification, or processing.

Together, these tests provide a more complete assessment of batch quality, consistency, and manufacturing control. OROS Research believes researchers deserve access to meaningful quality data, which is why batch-specific Certificates of Analysis are made publicly accessible whenever available.

Where can I find the Certificate of Analysis (COA)?

COA reports are available on each product page within the product image gallery. Current and previous batch information, including lot numbers, manufacturing dates, expiration dates, and testing documentation, can also be found on our Lab Results Page.

We make COAs accessible so researchers can review relevant batch information before purchasing whenever documentation is available.

Is this product made in the USA?

Yes. OROS lyophilized products are formulated, sterile filled, lyophilized, vialed, and packaged in California at a qualified third-party manufacturing facility operating under controlled processes aligned with cGMP principles.

Raw materials may be sourced from domestic and international suppliers that adhere to established quality standards, including GMP-aligned systems and ISO-based frameworks. Finished products undergo domestic formulation, lyophilization, quality review, and independent third-party testing in the United States.

Why do you not source your raw materials exclusively from the USA?

The majority of active pharmaceutical ingredients and specialty research materials used worldwide, including those used by many U.S. pharmaceutical manufacturers and compounding facilities, are produced overseas. Our manufacturing partner sources domestically when possible; however, it is not always feasible to source 100% of raw materials exclusively from the United States.

What matters most is supplier qualification, manufacturing controls, domestic formulation and lyophilization, and independent third-party testing. Finished OROS batches undergo analytical verification prior to release to support quality, consistency, and transparency.

How is it shipped?

All orders are shipped from North Carolina via UPS, with Ground, 2-Day, and Express delivery options available at checkout. Orders over $150 qualify for complimentary UPS 2-Day Shipping.

Every order includes complimentary full-value shipment insurance. In the event of loss, damage, or theft during transit, our team will work with the carrier to initiate the claims process and help facilitate a resolution as quickly as possible.

Do you ship with cold packs or temperature control?

No. We do not ship lyophilized products with cold packs or cold-chain carrier services. Lyophilized compounds are manufactured to remain stable in a dry, sealed state during normal shipping conditions.

Cold packs can introduce unnecessary condensation, moisture exposure, and temperature cycling inside the package during transit. For lyophilized research materials, protective packaging and prompt carrier delivery are typically preferred over unnecessary cold packing.

Short-term exposure to elevated temperatures during standard transit windows does not necessarily indicate product degradation. Degradation risk is more closely associated with sustained exposure to high heat, humidity, or improper long-term storage.

Where do you ship?

We currently ship to U.S. addresses only. We do not ship to PO Boxes, international destinations, military bases, U.S. territories, or freight forwarding services at this time.

What payment methods do you accept?

We accept all major debit and credit cards. Gift cards, international cards, HSAs, FSAs, and insurance are not accepted.

After checkout, customers must complete our secure Payment Authorization Form. Orders are not processed or shipped until authorization is completed and payment has been reviewed.

This workflow is designed to support secure payment handling and protect customer payment information. OROS Research does not store customer card information on file for future use.

Do you accept returns?

Due to the sensitive nature of our products, all sales are final. We do not accept returns or exchanges once an order has been fulfilled.

If an issue occurs with your order, please contact support@orosresearch.com within 7 days of delivery so our team can review the situation and determine the appropriate next steps.

How should this product be stored?

Before reconstitution, lyophilized products should be stored in a cool, dry environment away from direct light, heat, and humidity. For longer-term storage, freezer conditions are generally preferred for many lyophilized research materials.

Once reconstituted, materials should be handled and stored according to your laboratory’s internal research protocols, study design, and established handling procedures.

Looking for more answers?

Visit our Full FAQ Page for additional information on ordering, account access, shipping, storage, COAs, returns, and product support.